2 -pyridine carboxamide derivatives as sodium channel modulators

Details for Australian Patent Application No. 2008247102 (hide)

Owner Pfizer Limited

Inventors Kemp, Mark Ian; Denton, Stephen Martin; Bagal, Sharanjeet Kaur; Gibson, Karl Richard; Stammen, Blanda Luzia; Poinsard, Cedric; Glossop, Melanie Susanne

Agent Spruson & Ferguson

Pub. Number AU-B-2008247102

PCT Pub. Number WO2008/135826

Priority 60/957,536 23.08.07 US; 60/915,745 03.05.07 US

Filing date 21 April 2008

Wipo publication date 13 November 2008

Acceptance publication date 24 November 2011

International Classifications

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/4439 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/135826 Priority application(s): WO2008/135826

24 November 2011 Application Accepted

  Published as AU-B-2008247102

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008247116-Armature and solenoid assembly

2008247095-Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5 - methyl-2,2diphenylhexanamide